Bone mineral density screening and its accordance with Canadian clinical practice guidelines from 2000-2013: an unchanging landscape in Saskatchewan, Canada
- PMID: 26173601
- DOI: 10.1007/s11657-015-0227-2
Bone mineral density screening and its accordance with Canadian clinical practice guidelines from 2000-2013: an unchanging landscape in Saskatchewan, Canada
Abstract
We examined the clinical characteristics of patients who underwent initial dual energy X-ray absorptiometry (DXA) testing at a primary care facility from 2000 to 2013, and whether these factors changed over time in accordance with Canadian clinical practice guidelines. The burden of osteoporosis remains high and largely unchanged and clinical practice guidelines are not being followed, overall.
Purpose: This study examined the clinical risk factors, therapeutic health behaviors, and bone mineral density (BMD) status of patients who underwent initial DXA testing at a primary care facility in Saskatchewan, Canada, and whether these factors changed over time from 2000 to 2013 in accordance with Canadian clinical practice guidelines.
Methods: We conducted a retrospective cross-sectional medical chart audit of 800 patients 50 years of age and older who underwent their first DXA test to assess BMD status. Data was extracted from 2000 to 2013 and further stratified into four periods (2000-2001, 2002-2006, 2007-2009, and 2010-2013; n = 200 each period) based on the years when practice guidelines were implemented. Extracted data included BMD outcomes, clinical risk factor indicators for DXA testing, and recommendations for therapeutic health behaviors outlined in the clinical practice guidelines.
Results: There were no differences in BMD status across the four time stratas (p = 0.430). Overall, most clinical risk factors had little change over time. The number of males screened significantly increased over time (p < 0.05), and osteoporosis drug therapy use decreased from 2000-2001 to 2010-2013 (p < 0.001). Increasing age, body mass <60 kg, and history of adult fracture were significant independent predictors of osteoporosis diagnosis.
Conclusions: The burden of osteoporosis remains high and largely unchanged in Saskatchewan, Canada. These results serve to inform strategies to enhance health-care provider awareness and compliance with practice guidelines, as well as improve screening rates and patient health behaviors.
Similar articles
-
Pharmacist Screening for Risk of Osteoporosis in Elderly Veterans.Consult Pharm. 2016;31(8):440-9. doi: 10.4140/TCP.n.2016.440. Consult Pharm. 2016. PMID: 27535079
-
Osteoporosis screening for men: are family physicians following the guidelines?Can Fam Physician. 2008 Aug;54(8):1140-1141, 1141.e1-5. Can Fam Physician. 2008. PMID: 18697977 Free PMC article.
-
Implementation and adherence to osteoporosis screening guidelines among coeliac disease patients.Dig Liver Dis. 2016 Dec;48(12):1451-1456. doi: 10.1016/j.dld.2016.08.121. Epub 2016 Sep 5. Dig Liver Dis. 2016. PMID: 27665261
-
Use of Trabecular Bone Score (TBS) as a Complementary Approach to Dual-energy X-ray Absorptiometry (DXA) for Fracture Risk Assessment in Clinical Practice.J Clin Densitom. 2017 Jul-Sep;20(3):334-345. doi: 10.1016/j.jocd.2017.06.019. Epub 2017 Jul 19. J Clin Densitom. 2017. PMID: 28734710 Review.
-
Worldwide Fracture Prediction.J Clin Densitom. 2017 Jul-Sep;20(3):397-424. doi: 10.1016/j.jocd.2017.06.008. Epub 2017 Jul 19. J Clin Densitom. 2017. PMID: 28734709 Review.
Cited by
-
Acupoint injection treatment for primary osteoporosis: A systematic review and meta-analysis of randomized controlled trials protocol.Medicine (Baltimore). 2019 Aug;98(32):e16735. doi: 10.1097/MD.0000000000016735. Medicine (Baltimore). 2019. PMID: 31393383 Free PMC article.
-
Moxibustion treatment for primary osteoporosis: A systematic review of randomized controlled trials.PLoS One. 2017 Jun 7;12(6):e0178688. doi: 10.1371/journal.pone.0178688. eCollection 2017. PLoS One. 2017. PMID: 28591176 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical